vs

Side-by-side financial comparison of Inogen Inc (INGN) and Strategy Inc (MSTR). Click either name above to swap in a different company.

Strategy Inc is the larger business by last-quarter revenue ($123.0M vs $68.6M, roughly 1.8× Inogen Inc). On growth, Inogen Inc posted the faster year-over-year revenue change (3.4% vs 1.9%). Over the past eight quarters, Inogen Inc's revenue compounded faster (4.2% CAGR vs 3.3%).

Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.

Strategy Inc., formerly known as MicroStrategy, is an American company that provides business intelligence (BI) and mobile software. Founded in 1989 by Michael J. Saylor, Sanju Bansal, and Thomas Spahr, the firm develops software to analyze internal and external data in order to make business decisions and to develop mobile apps. It is a public company headquartered in Tysons Corner, Virginia, in the Washington metropolitan area. Its primary business analytics competitors include SAP SE Busin...

INGN vs MSTR — Head-to-Head

Bigger by revenue
MSTR
MSTR
1.8× larger
MSTR
$123.0M
$68.6M
INGN
Growing faster (revenue YoY)
INGN
INGN
+1.5% gap
INGN
3.4%
1.9%
MSTR
Faster 2-yr revenue CAGR
INGN
INGN
Annualised
INGN
4.2%
3.3%
MSTR

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
INGN
INGN
MSTR
MSTR
Revenue
$68.6M
$123.0M
Net Profit
Gross Margin
51.4%
66.1%
Operating Margin
-13.6%
Net Margin
Revenue YoY
3.4%
1.9%
Net Profit YoY
EPS (diluted)
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INGN
INGN
MSTR
MSTR
Q4 25
$68.6M
$123.0M
Q3 25
$79.1M
$128.7M
Q2 25
$79.2M
$114.5M
Q1 25
$68.5M
$111.1M
Q4 24
$66.3M
$120.7M
Q3 24
$74.9M
$116.1M
Q2 24
$74.4M
$111.4M
Q1 24
$63.1M
$115.2M
Net Profit
INGN
INGN
MSTR
MSTR
Q4 25
Q3 25
$-5.3M
$2.8B
Q2 25
$-4.2M
$10.0B
Q1 25
$-6.2M
$-4.2B
Q4 24
$-670.8M
Q3 24
$-6.0M
$-340.2M
Q2 24
$-5.6M
$-102.6M
Q1 24
$-14.6M
$-53.1M
Gross Margin
INGN
INGN
MSTR
MSTR
Q4 25
51.4%
66.1%
Q3 25
52.2%
70.5%
Q2 25
52.2%
68.8%
Q1 25
53.1%
69.4%
Q4 24
54.7%
71.7%
Q3 24
55.2%
70.4%
Q2 24
57.4%
72.2%
Q1 24
54.5%
74.0%
Operating Margin
INGN
INGN
MSTR
MSTR
Q4 25
-13.6%
Q3 25
-9.0%
Q2 25
-7.7%
Q1 25
-11.2%
-5331.4%
Q4 24
-17.2%
-842.1%
Q3 24
-10.4%
-372.7%
Q2 24
-9.5%
-179.7%
Q1 24
-25.8%
-176.8%
Net Margin
INGN
INGN
MSTR
MSTR
Q4 25
Q3 25
-6.7%
2164.1%
Q2 25
-5.2%
8752.7%
Q1 25
-9.0%
-3797.2%
Q4 24
-555.8%
Q3 24
-8.0%
-293.1%
Q2 24
-7.5%
-92.0%
Q1 24
-23.1%
-46.1%
EPS (diluted)
INGN
INGN
MSTR
MSTR
Q4 25
$-0.26
Q3 25
$-0.20
$8.42
Q2 25
$-0.15
$32.60
Q1 25
$-0.25
$-16.49
Q4 24
$-0.41
$4.49
Q3 24
$-0.25
$-1.72
Q2 24
$-0.24
$-0.57
Q1 24
$-0.62
$-0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INGN
INGN
MSTR
MSTR
Cash + ST InvestmentsLiquidity on hand
$103.7M
$2.3B
Total DebtLower is stronger
$8.2B
Stockholders' EquityBook value
$192.2M
$44.1B
Total Assets
$298.6M
$61.6B
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INGN
INGN
MSTR
MSTR
Q4 25
$103.7M
$2.3B
Q3 25
$106.5M
$54.3M
Q2 25
$103.7M
$50.1M
Q1 25
$118.9M
$60.3M
Q4 24
$113.8M
$38.1M
Q3 24
$105.7M
$46.3M
Q2 24
$97.9M
$66.9M
Q1 24
$107.4M
$81.3M
Total Debt
INGN
INGN
MSTR
MSTR
Q4 25
$8.2B
Q3 25
$8.2B
Q2 25
$8.2B
Q1 25
$8.1B
Q4 24
$7.2B
Q3 24
$4.2B
Q2 24
$3.8B
Q1 24
$3.6B
Stockholders' Equity
INGN
INGN
MSTR
MSTR
Q4 25
$192.2M
$44.1B
Q3 25
$197.2M
$52.3B
Q2 25
$199.5M
$47.5B
Q1 25
$198.0M
$32.2B
Q4 24
$173.9M
$18.2B
Q3 24
$185.4M
$3.8B
Q2 24
$187.6M
$2.8B
Q1 24
$191.9M
$2.4B
Total Assets
INGN
INGN
MSTR
MSTR
Q4 25
$298.6M
$61.6B
Q3 25
$307.0M
$73.6B
Q2 25
$312.0M
$64.8B
Q1 25
$308.4M
$43.9B
Q4 24
$296.2M
$25.8B
Q3 24
$306.2M
$8.3B
Q2 24
$308.9M
$7.1B
Q1 24
$315.6M
$6.4B
Debt / Equity
INGN
INGN
MSTR
MSTR
Q4 25
0.19×
Q3 25
0.16×
Q2 25
0.17×
Q1 25
0.25×
Q4 24
0.39×
Q3 24
1.12×
Q2 24
1.36×
Q1 24
1.48×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INGN
INGN
MSTR
MSTR
Operating Cash FlowLast quarter
$-943.0K
Free Cash FlowOCF − Capex
$-1.9M
FCF MarginFCF / Revenue
-2.8%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-13.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INGN
INGN
MSTR
MSTR
Q4 25
$-943.0K
Q3 25
$2.2M
$-8.3M
Q2 25
$4.3M
$-34.9M
Q1 25
$-16.8M
$-2.4M
Q4 24
$-3.0M
$-17.3M
Q3 24
$7.0M
$-41.0M
Q2 24
$6.7M
$-23.3M
Q1 24
$-4.7M
$28.6M
Free Cash Flow
INGN
INGN
MSTR
MSTR
Q4 25
$-1.9M
Q3 25
$1.6M
$-11.1M
Q2 25
$3.7M
$-37.0M
Q1 25
$-17.1M
$-5.1M
Q4 24
$-3.3M
$-17.6M
Q3 24
$5.3M
$-41.4M
Q2 24
$6.6M
$-24.1M
Q1 24
$-6.1M
$27.0M
FCF Margin
INGN
INGN
MSTR
MSTR
Q4 25
-2.8%
Q3 25
2.0%
-8.6%
Q2 25
4.6%
-32.3%
Q1 25
-24.9%
-4.6%
Q4 24
-5.0%
-14.6%
Q3 24
7.1%
-35.7%
Q2 24
8.9%
-21.6%
Q1 24
-9.6%
23.5%
Capex Intensity
INGN
INGN
MSTR
MSTR
Q4 25
1.4%
Q3 25
0.7%
2.2%
Q2 25
0.9%
1.8%
Q1 25
0.4%
2.5%
Q4 24
0.5%
0.2%
Q3 24
2.2%
0.4%
Q2 24
0.1%
0.6%
Q1 24
2.1%
1.3%
Cash Conversion
INGN
INGN
MSTR
MSTR
Q4 25
Q3 25
-0.00×
Q2 25
-0.00×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INGN
INGN

Other$36.1M53%
Non Us$32.5M47%

MSTR
MSTR

Segment breakdown not available.

Related Comparisons